paclitaxel,epirubicin,capecitabine,leucovorin,5-fluorouracil,docetaxel,carboplatin,oxaliplatin,cisplatin
Not Tagged
[]
the #oncoalerttoptweet for day1 #gi23 tweet neo-aegis:flot v cross for esoph/gej (n=362) 362 pts. no dif in 3-yr os (57% v 55%), though path outcomes improved w chemort. not surprised that for all-comers no dif, clearly not one size fits all 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨